JB Chemicals has received US FDA approval to market its generic version of Amitriptyline Hydrochloride tablets, used to treat depression.

The issue comprised 1.51 crore shares segmented across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs). However, only 6.64 lakh shares…

According to NSE data, the issue received bids for 20,35,764 shares against the 2,28,26,516 shares on offer. The retail individual investors (RIIs) portion saw a…

Kaynes Technology has closed its Qualified Institutions Placement, raising funds by allotting nearly 29 lakh shares at ₹5,569.50 apiece, at a 1% discount to the…

The Nifty Bank index extended its rebound for a second consecutive session. While the index showed continued strength, it faced resistance near the 56,800 level.…

Dyrupeg, used to reduce the risk of infection in patients undergoing chemotherapy, had earlier secured marketing authorisation from the European Commission in April 2025. Shares…

With the rapid increase in investor base and volumes, and a growing network of intermediaries associated with the market infrastructure institutions (MIIs), SEBI’s proposal aims…

Last week, Bajel Projects secured an ‘ultra-mega’ transmission order from PowerGrid for a project worth over ₹400 crore. Shares of Bajel Projects Ltd ended at…

As of March 2025, Timex Group Luxury Watches BV held a 74.93% stake in Timex Group India. Shares of Timex Group India Ltd ended at ₹262.50,…

Nikhil Bhandari, Co-Head of APAC Natural Resources & Clean Energy Research at Goldman Sachs, believes that the most reliable investment returns in India’s power sector…